Synergy CHC Corp. (SNYR) Earnings Call Transcripts

Synergy CHC Corp.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of 2025, Synergy CHC Corp. reported a significant decline in net revenue to $6.07 million, down 41% year-over-year, primarily due to the reversal of $2.9 million in licensing revenue following the termination of an international agreement. The company also posted a net loss of $14.82 million, or $1.35 per diluted share, compared to a net income of $105,700 in the same quarter last year. Management signaled a challenging transition year but expressed optimism about future growth, particularly in their beverage division, which is expected to be foundational in 2026, with a run rate of $2.5 million already achieved in the first quarter.

Reported metrics

Guidance from management

Management anticipates that 2026 will be a foundational growth year, particularly for the beverage division, with a run rate of $2.5 million already achieved in Q1. They expect gross margins to stabilize or improve, excluding one-time items.

What management said

We -- as you know, we just raised the money to actually build the inventory in August. -- and to actually get the inventory built takes time, meaning 8 to 12 weeks to build the inventory. So we just really received the majority of the RTD inventory in-house in December. So that's what affected that.

No. Flat Tummy continues to decline. The weight loss business is being heavily impacted by the GLP1s. It seems that the whole industry has moved to those. So we'll be making a strategic decision on flat come in the near future.

What analysts pressed on

Analysts expressed concerns regarding the ongoing decline in the Flat Tummy brand due to competitive pressures from GLP-1 medications. Additionally, there were questions about the impact of increased operating expenses and the timeline for resuming TV advertising to drive sales growth.

Main topics on the call

• Significant Revenue Decline — Net revenue for Q4 2025 was $6.07 million, a 41% decrease from $10.27 million in Q4 2024, primarily due to the termination of a licensing agreement. Management noted, "Without that reversal, net revenue was $8.97 million...
• Increased Operating Expenses — Operating expenses surged to $15.53 million from $5.14 million year-over-year, largely due to one-time items including a $6.6 million allowance for bad debt. Management stated, "The majority of the increase was due to pr...
• Beverage Division Growth — Management highlighted that the beverage division generated over $600,000 in gross revenue in Q1 2026, surpassing the entire revenue for 2025. They expect 2026 to be a foundational growth year for this segment, stating, ...
• International Expansion Challenges — The termination of the international license agreement was a setback, but management remains optimistic about the UAE and Turkey markets. Jack Ross mentioned, "The groundwork we laid in 2025 hasn't been lost, the demand ...

Read the full Synergy CHC Corp. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 6 Synergy CHC Corp. earnings call transcripts on record, spanning December 6, 2024 to June 29, 2026. Based on this history, Synergy CHC Corp. reports quarterly. The most recent call on file is dated June 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

SNYR

Exchange

NasdaqCM

Country

US

Sector

Consumer Staples

Industry

Personal Care Products

Calls on record

6

First call

December 6, 2024

Most recent

June 29, 2026

Reporting cadence

quarterly